您好, 歡迎來到化工儀器網(wǎng)! 登錄| 免費注冊| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:上海一基實業(yè)有限公司>>生物試劑>>其他生化試劑>> 355025-13-7Ki16198 355025-13-7
產(chǎn)品型號355025-13-7
品 牌
廠商性質(zhì)經(jīng)銷商
所 在 地上海市
更新時間:2024-11-17 13:32:00瀏覽次數(shù):555次
聯(lián)系我時,請告知來自 化工儀器網(wǎng)Ki16198 355025-13-7
Ki-16198
分子式:C24H25ClN2O5S 分子量:488.98
產(chǎn)品描述
Ki16198, Ki16425的甲酯, 是LPA 拮抗劑,抑制LPA1-和 LPA3誘導(dǎo)的肌醇磷酸產(chǎn)生,Ki分別為0.34 μM 和0.93 μM,對LPA2具有較弱的抑制作用,對LPA4, LPA5, LPA6沒有抑制活性。
靶點
LPA1
LPA3
IC50
0.34 μM (Ki)
0.93 μM (Ki)
體外研究
Ki16198 or Ki16425 substantially inhibits LPA1- and LPA3-mediated responses with a similar potency, with low potency to LPA2 and no activity to LPA4, LPA5 and LPA6. Ki16198 (10 μM) is also effective to inhibit migration and invasion responses to LPA in YAPC-PD cancer cell line with a potency similar to that of Ki16425. Ki16198 (10 μM) inhibits the LPA-induced expression of proMMP-9 protein and mRNA in YAPC-PD cells.Ki16198 (1 μM) inhibits the proliferation of lpa1Δ-1 and lpa1Δ+-1 cells by about 70%.
體內(nèi)研究
Ki16198 (2 mg/kg) significantly decreases the total metastatic node weight in the peritoneal cavity and ascites formation by 50% in YAPC-PD xenograft mouse model.Ki16198 (60 mg/kg orally) significantly inhibits lactate-induced limb lesions in rats.
溶解性
DMSO 96 mg/mL,水 <1 mg/mL,乙醇 35 mg/mL
穩(wěn)定性
2年 -20°C粉狀,6月-80°C溶于DMSO
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。